iFIT Seminar Series Session with Dr. Steve Pascolo
"Vaccines and therapies based on synthetic mRNA"
On behalf of the iFIT spokespersons Lars Zender, Hans-Georg Rammensee and Bernd Pichler, it is our pleasure to inform you about and invite you to the next iFIT Seminar Series Session 2024 that will take place
on Monday, January 15th at 12:00 pm (CET)
at Big Lecture Hall in the Medical Clinic (Medizinische Klinik, Otfried-Müller-Straße 10 72076 Tübingen).
Our guest speaker, Dr. Steve Pascolo (University of Zurich, University Research Priority Programs, Translational Cancer Research) will give a talk on
“Vaccines and therapies based on synthetic mRNA”.
Trained as an immunologist at the Pasteur Institute (Paris, France), Dr. Steve Pascolo used mouse models to test and develop mRNA-based vaccines (direct injection of mRNA) during his post-doc in Tuebingen, Germany from 1998 till 2000. In 2000, he co-founded CureVac with Dr. Hoerr and Dr. von der Mulbe. Dr. Pascolo was Chief Scientific Officer (CSO) of the company from 2000 till 2006, developing the technology, implementing the worldwide first pharmaceutical (GMP) production of synthetic mRNA and starting in 2003 the worldwide first clinical studies where humans (including himself) got injections of in vitro transcribed mRNA. In 2006, he joined the oncology department of the University Hospital of Zurich, Switzerland and continued the development of immunotherapies based on RNA. In 2008, he founded Miescher Pharma to support this work. In 2013, he joined the dermatology department of the University Hospital of Zurich, Switzerland. In 2017, Dr. Pascolo implemented in the University of Zurich an academic mRNA platform. In collaboration with several research and clinical departments in Zurich he optimizes, tests and implements mRNA based vaccines and therapies.
As a special feature of this program, the iFIT will sponsor free lunch packages! (First come, first serve)
All members of the University Hospital and University of Tübingen are invited to participate!
We look forward to this Seminar Series session and to see you there!
